4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-24-000265
Director sold 73,730 shares at an average $243.93 ($17,984,804)
- Director acquired 73,730 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2024-04-03 | Option exercise 10b5-1 | +27,407 | $9.45 | $258,996 | 213,142 | D |
| FRIEDMAN PAUL A Director | 2024-04-03 | Sale 10b5-1 | −185 | $242.00 | $44,770 | 212,957 | D |
| FRIEDMAN PAUL A Director | 2024-04-03 | Sale 10b5-1 | −2,294 | $243.64 | $558,921 | 210,663 | D |
| FRIEDMAN PAUL A Director | 2024-04-03 | Sale 10b5-1 | −4,301 | $244.58 | $1,051,959 | 206,362 | D |
| FRIEDMAN PAUL A Director | 2024-04-03 | Sale 10b5-1 | −18,806 | $245.34 | $4,613,823 | 187,556 | D |
| FRIEDMAN PAUL A Director | 2024-04-03 | Sale 10b5-1 | −1,821 | $246.31 | $448,530 | 185,735 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Option exercise 10b5-1 | +18,710 | $9.45 | $176,810 | 204,445 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −6,273 | $241.07 | $1,512,222 | 198,172 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −5,299 | $242.25 | $1,283,679 | 192,873 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −1,467 | $243.00 | $356,482 | 191,406 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −627 | $244.31 | $153,185 | 190,779 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −2,549 | $245.14 | $624,857 | 188,230 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −1,558 | $246.13 | $383,471 | 186,672 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −737 | $247.14 | $182,141 | 185,935 | D |
| FRIEDMAN PAUL A Director | 2024-04-04 | Sale 10b5-1 | −200 | $248.43 | $49,685 | 185,735 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Option exercise 10b5-1 | +27,613 | $9.45 | $260,943 | 213,348 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −1,420 | $240.10 | $340,939 | 211,928 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −612 | $241.15 | $147,582 | 211,316 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −6,679 | $242.42 | $1,619,098 | 204,637 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −9,264 | $243.20 | $2,253,016 | 195,373 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −3,966 | $244.22 | $968,588 | 191,407 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −5,228 | $245.35 | $1,282,669 | 186,179 | D |
| FRIEDMAN PAUL A Director | 2024-04-05 | Sale 10b5-1 | −444 | $245.92 | $109,189 | 185,735 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2024-04-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,407 | 278,849 | D | ||
| FRIEDMAN PAUL A Director | 2024-04-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,710 | 260,139 | D | ||
| FRIEDMAN PAUL A Director | 2024-04-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,613 | 232,526 | D | ||
| Open-market sales · 73,730 sh · avg $243.93 · $17,984,804 | |||||||
Loading xslF345X05/doc4.xml…